Commentary by Keith Kawashima | 2023 Top Risks Survey — Pharmaceuticals and Life Sciences

1 min read

Managing Director Keith Kawashima provides an overview of the risk landscape for pharmaceuticals and life sciences organizations based on research from Protiviti's 2023 Top Risks Survey.

Loading...